组织工程与重建外科杂志
組織工程與重建外科雜誌
조직공정여중건외과잡지
JOURNAL OF TISSUE ENGINEERING AND RECONSTRUCTIVE SURGERY
2014年
6期
324-328
,共5页
沈聪聪%柴岗%曲淼%侯亦康%许祐荣%张艳
瀋聰聰%柴崗%麯淼%侯亦康%許祐榮%張豔
침총총%시강%곡묘%후역강%허우영%장염
瘢痕成纤维细胞%软骨细胞%软骨形态发生蛋白1%诱导分化
瘢痕成纖維細胞%軟骨細胞%軟骨形態髮生蛋白1%誘導分化
반흔성섬유세포%연골세포%연골형태발생단백1%유도분화
Hypertrophic scar fibroblasts%Chondrocytes%Cartilage-derived morphogenetic protein 1%Transdifferention
目的:探讨软骨形态发生蛋白1(CDMP1)诱导的瘢痕成纤维细胞在体内环境下的软骨构建能力。方法取瘢痕切除术后丢弃的增生性瘢痕组织,提取瘢痕成纤维细胞。将瘢痕成纤维细胞与PGA/PLA支架复合,CDMP1软骨诱导液(CDMP1终浓度为100 ng/mL)进行诱导培养2周,设为诱导组(n=10);将常规培养液培养的瘢痕成纤维细胞-材料复合物植入裸鼠体内作为阴性对照,设为非诱导组(n=4);将软骨细胞-材料复合物植入裸鼠体内作为阳性对照,设为软骨组(n=4)。分别于4周和8周后取材,进行各组湿重、糖胺聚糖(GAG)含量测定,HE染色、Safranine-O染色和Ⅱ型胶原免疫组化染色。结果体内培养4周、8周后各组湿重、GAG含量测定显示,诱导组均高于非诱导组(P<0.05)。体内培养4周后,诱导组HE染色结果显示,瘢痕成纤维细胞诱导后出现软骨细胞陷窝结构;Safranine-O染色结果示,GAG均匀分布于基质;免疫组织化学染色示部分瘢痕成纤维细胞基质中COLⅡ阳性表达。8周时,诱导组的类软骨结果相对4周时更加成熟,更加符合软骨结构分布。结论在CDMP1诱导下,瘢痕成纤维细胞与PGA/PLA材料复合,在体内可以形成类软骨组织,具备一定的成软骨能力。
目的:探討軟骨形態髮生蛋白1(CDMP1)誘導的瘢痕成纖維細胞在體內環境下的軟骨構建能力。方法取瘢痕切除術後丟棄的增生性瘢痕組織,提取瘢痕成纖維細胞。將瘢痕成纖維細胞與PGA/PLA支架複閤,CDMP1軟骨誘導液(CDMP1終濃度為100 ng/mL)進行誘導培養2週,設為誘導組(n=10);將常規培養液培養的瘢痕成纖維細胞-材料複閤物植入裸鼠體內作為陰性對照,設為非誘導組(n=4);將軟骨細胞-材料複閤物植入裸鼠體內作為暘性對照,設為軟骨組(n=4)。分彆于4週和8週後取材,進行各組濕重、糖胺聚糖(GAG)含量測定,HE染色、Safranine-O染色和Ⅱ型膠原免疫組化染色。結果體內培養4週、8週後各組濕重、GAG含量測定顯示,誘導組均高于非誘導組(P<0.05)。體內培養4週後,誘導組HE染色結果顯示,瘢痕成纖維細胞誘導後齣現軟骨細胞陷窩結構;Safranine-O染色結果示,GAG均勻分佈于基質;免疫組織化學染色示部分瘢痕成纖維細胞基質中COLⅡ暘性錶達。8週時,誘導組的類軟骨結果相對4週時更加成熟,更加符閤軟骨結構分佈。結論在CDMP1誘導下,瘢痕成纖維細胞與PGA/PLA材料複閤,在體內可以形成類軟骨組織,具備一定的成軟骨能力。
목적:탐토연골형태발생단백1(CDMP1)유도적반흔성섬유세포재체내배경하적연골구건능력。방법취반흔절제술후주기적증생성반흔조직,제취반흔성섬유세포。장반흔성섬유세포여PGA/PLA지가복합,CDMP1연골유도액(CDMP1종농도위100 ng/mL)진행유도배양2주,설위유도조(n=10);장상규배양액배양적반흔성섬유세포-재료복합물식입라서체내작위음성대조,설위비유도조(n=4);장연골세포-재료복합물식입라서체내작위양성대조,설위연골조(n=4)。분별우4주화8주후취재,진행각조습중、당알취당(GAG)함량측정,HE염색、Safranine-O염색화Ⅱ형효원면역조화염색。결과체내배양4주、8주후각조습중、GAG함량측정현시,유도조균고우비유도조(P<0.05)。체내배양4주후,유도조HE염색결과현시,반흔성섬유세포유도후출현연골세포함와결구;Safranine-O염색결과시,GAG균균분포우기질;면역조직화학염색시부분반흔성섬유세포기질중COLⅡ양성표체。8주시,유도조적류연골결과상대4주시경가성숙,경가부합연골결구분포。결론재CDMP1유도하,반흔성섬유세포여PGA/PLA재료복합,재체내가이형성류연골조직,구비일정적성연골능력。
Objective To explore the chondrogenesis potential of hypertrophic scar fibroblasts (HSFBs) induced by cartilage-derived morphogenetic protein 1 (CDMP1) in vivo. Methods Hypertrophic scar fibroblasts (HSFBs) were isolated from discarded hypertrophic scar. HSFBs combining with PGA/PLA scaffold as HSFBs- PGA/PLA complex were induced by CDMP1 (100 ng/mL) for 2 weeks. Then the complex were transplanted into nude mice as induced group (n=10). The complex that not induced were treated as negative control, named as un-induced group ( n=4), while the chondrocytes-PGA/PLA complex were treated as positive control, named as chondrocyte group (n=4). After 4 and 8 weeks, the complex in each group was harvested for wet weight test, proteoglycan (GAG) content test, HE staining, Safranine-O staining and immunochemistry staining. Results After 4 and 8 weeks in vivo, the wet weight and GAG content in induced group were both higher than in un-induced group (P<0.05). In induced group, after cultured for 4 weeks in vivo, chondrocyte-like lacuna structure was observed by HE staining, uniform distribution of GAG was observed by Safranine-O staining, and positive expression of collagen type Ⅱ was revealed by immunohistochemical staining. After 8 weeks of culturing in vivo, chondrocyte-like structure in induced group was more mature and more in line with the structure distribution of cartilage. Conclusion HSFBs combining with PGA/PLA had the potential to develop into polygonal chondrocyte-like tissue by the induction of CDMP 1.